Clinical Trial Update: Efficacy Study of Lisdexamfetamine to Treat Binge Eating Disorder [Phase 3]

View source ↗

Summary

A Phase 3 efficacy study of lisdexamfetamine for binge eating disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Binge Eating Disorder

Drugs mentioned

• Vyvanse (lisdexamfetamine dimesylate)

Snippet

Sponsor: Lindner Center of HOPE | Conditions: Binge Eating Disorder | Phase 3 | Status: COMPLETED